ロード中...
Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial)
BACKGROUND: Eighty percent of children with steroid-sensitive nephrotic syndrome (SSNS) relapse within 2 years and 40–50% patients show frequently-relapsing nephrotic syndrome (FRNS). Patients showing a relapse within 6 months after initial remission are at high risk of FRNS. Since frequent predniso...
保存先:
| 出版年: | BMC Nephrol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6131840/ https://ncbi.nlm.nih.gov/pubmed/30200895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-018-1033-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|